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XLF and H2AX function in series to promote
replication fork stability
Bo-Ruei Chen1*, Annabel Quinet2*, Andrea K. Byrum3, Jessica Jackson2, Matteo Berti2, Saravanabhavan Thangavel2, Andrea L. Bredemeyer3,
Issa Hindi1, Nima Mosammaparast3, Jessica K. Tyler1, Alessandro Vindigni2, and Barry P. Sleckman1
XRCC4-like factor (XLF) is a non-homologous end joining (NHEJ) DNA double strand break repair protein. However, XLF
deficiency leads to phenotypes in mice and humans that are not necessarily consistent with an isolated defect in NHEJ. Here we
show that XLF functions during DNA replication. XLF undergoes cell division cycle 7–dependent phosphorylation; associates
with the replication factor C complex, a critical component of the replisome; and is found at replication forks. XLF deficiency
leads to defects in replication fork progression and an increase in fork reversal. The additional loss of H2AX, which protects
DNA ends from resection, leads to a requirement for ATR to prevent anMRE11-dependent loss of newly synthesized DNA and
activation of DNA damage response. Moreover, H2ax−/−:Xlf−/− cells exhibit a marked dependence on the ATR kinase for
survival. We propose that XLF and H2AX function in series to prevent replication stress induced by the MRE11-dependent
resection of regressed arms at reversed replication forks.
Introduction
Faithful replication of the genome in dividing cells relies on a
network of sophisticated DNA replication mechanisms that are
orchestrated in a temporally controlled manner (Masai et al.,
2010; Fragkos et al., 2015). Defects in these events can hinder
replication fork progression, leading to replication fork stalling
and replication stress (Zeman and Cimprich, 2014; Berti and
Vindigni, 2016). Replication fork stalling can lead to activation
of the ataxia-telangiectasia and Rad3-related (ATR) kinase, a
critical regulator of replication stress responses and the S-phase
checkpoint (Zou and Elledge, 2003; Cimprich and Cortez, 2008;
Nam and Cortez, 2011; Saldivar et al., 2017). Stalled replication
forks can undergo fork reversal, where newly synthesized
(nascent) DNA strands dissociate from template strands and
anneal to each other, forming a regressed arm (Sogo et al., 2002;
Quinet et al., 2017b). Several proteins are known to promote fork
reversal, including RAD51, SMARCAL1, HLTF, and ZRANB3
(Zellweger et al., 2015; Kolinjivadi et al., 2017; Quinet et al.,
2017b; Taglialatela et al., 2017; Vujanovic et al., 2017). ATR
phosphorylates SMARCAL1, providing a link between ATR ac-
tivation and fork reversal (Couch et al., 2013). While fork re-
versal may be a mechanism for limiting replication stress,
failure to restart stalled replication forks can result in replica-
tion fork collapse, activation of a DNA damage response (DDR),
and cell death (Ciccia and Elledge, 2010; Neelsen and Lopes,
2015; Quinet et al., 2017b).
Non-homologous end joining (NHEJ) is a major pathway of
DNA double strand break (DSB) repair that directly joins broken
DNA ends (Chang et al., 2017). The XRCC4-like factor (XLF)
protein functions in NHEJ-mediated DNA DSB repair by forming
a filament with XRCC4 that aligns and stabilizes broken DNA
ends so they can be joined (Ahnesorg et al., 2006; Buck et al.,
2006; Andres et al., 2007; Zha et al., 2007; Li et al., 2008;
Hammel et al., 2011; Ropars et al., 2011; Fattah et al., 2014;
Brouwer et al., 2016). Deficiency of XLF in humans leads to se-
vere combined immunodeficiency consistent with a defect in
lymphocyte antigen receptor gene assembly by V(D)J recombi-
nation, a reaction that requires the generation of DNA DSBs by
the RAG endonuclease and their repair by NHEJ (Fugmann et al.,
2000; Ahnesorg et al., 2006; Buck et al., 2006; Helmink and
Sleckman, 2012). However, XLF-deficient murine lymphoid
cells do not exhibit overt defects in RAG DSB repair, raising the
possibility that XLF has additional functions that could con-
tribute to the phenotype of XLF deficiency (Li et al., 2008). In
this regard, cells derived from XLF-deficient patients have been
reported to have increased sensitivity to replicative stress
(Schwartz et al., 2009).
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The histone variant H2AX is phosphorylated (forming
γH2AX) by the DDR kinases ATM, DNA-dependent protein ki-
nase catalytic subunit (DNA-PKcs), and ATR in chromatin
flanking damaged DNA (Rogakou et al., 1998, 1999; Ward and
Chen, 2001; Savic et al., 2009; Blackford and Jackson, 2017).
γH2AX functions to retain DDR factors at DNA damage sites to
repair damaged DNA and amplify DDR signaling (Celeste et al.,
2002, 2003; Savic et al., 2009). γH2AX also protects broken DNA
ends from nucleolytic resection mediated by CtIP, and pre-
sumably MRE11, in G1-phase cells (Helmink et al., 2011). γH2AX
colocalizes with proliferating cell nuclear antigen (PCNA) foci
and has been implicated in the responses to replication stress
(Ward and Chen, 2001; Sirbu et al., 2011; Schmid et al., 2018).
Indeed, H2AX-deficient cells exhibit increased sensitivity to the
DNA replication inhibitor aphidicolin, especially when ATR is
inhibited (Chanoux et al., 2009).
Like XLF, H2AX is not required for NHEJ during RAG DSB
repair in murine lymphoid cells; however, a combined defi-
ciency of XLF and H2AX leads to a severe block in RAG DSB
repair in murine lymphoid cells, demonstrating that both of
these proteins have activities in NHEJ during V(D)J recombi-
nation in these cells (Zha et al., 2011). Xlf−/− andH2ax−/−mice are
both viable, but H2ax−/−:Xlf−/− mice exhibit embryonic lethality
at a developmental stage much earlier than mice deficient in the
core NHEJ factors, DNA ligase IV or XRCC4, suggesting that XLF
and H2AX function in fundamental cellular processes other than
NHEJ (Barnes et al., 1998; Frank et al., 1998; Gao et al., 1998; Zha
et al., 2011). Here we demonstrate that XLF-deficient cells have
DNA replication defects that lead to an increase in replication
fork reversal. Moreover, loss of H2AX in XLF-deficient cells
leads to a dependence on ATR to prevent a potent MRE11-
dependent DDR that would otherwise lead to cell death. We
propose that during DNA replication, XLF and H2AX function in
series to limit the formation of reversed replication forks (XLF)
and to protect regressed arms of reversed forks from being re-
sected by MRE11 (H2AX) and activating a DDR that can lead to
cell death. These important functions are independent of the
activities of XLF and H2AX in NHEJ.
Results and discussion
Association of XLF with DNA replication machinery
XLF from mouse embryonic fibroblasts (MEFs) or mouse Abel-
son virus–transformed preB cells (hereafter referred to as abl
preB cells) migrates as a doublet slightly below 38 kD (Fig. 1,
A–E). Phosphatase treatment leads to loss of the slower mi-
grating form, and coincubation with a phosphatase inhibitor
restores this form (Fig. 1 A). Neither inhibition of the ATR, ATM,
and DNA-PKcs DDR kinases nor mutation of murine XLF SQ/TQ
motifs (S55, S132, and T238) to AQ leads to loss of XLF phos-
phorylation (Fig. 1, C and D). However, mutation of serine 245 to
alanine leads to a complete loss of XLF phosphorylation, and
mutation of this serine to aspartic acid causes a complete shift to
the slower migrating form (Fig. 1, D and E). The CDK inhibitor
roscovitine had no effect on XLF phosphorylation (Fig. 1 C).
However, an inhibitor of the cell division cycle 7 (CDC7) kinase,
PHA-767491 (CDC7i), which is required to promote the initiation
of DNA synthesis (Fragkos et al., 2015), leads to reduced XLF
phosphorylation (Fig. 1, B and C).
We performed mass spectrometry of proteins that coimmu-
noprecipitate with a FLAG-HA–tagged XLF fusion protein ex-
pressed in Xlf−/− abl preB cells (Fig. 1 F and Table S1). As
previously reported, these analyses revealed that XLF associates
with the NHEJ factors Ku70, Ku80, DNA ligase IV, and XRCC4
(Fig. 1, F and G; Ahnesorg et al., 2006; Yano et al., 2008). Ad-
ditionally, we found that XLF also associates with all five com-
ponents of the replication factor C complex (RFC1–5), which
loads PCNA at replication forks (Fig. 1 F; Shiomi and Nishitani,
2017). Immunoprecipitation of XLF from MEFs confirmed that
XLF associates with RFC1 and RFC4 (Fig. 1 G). Thus, XLF is
phosphorylated by CDC7 and associates with RFC, suggesting
that XLF may function during DNA replication.
XLF associates with DNA replication forks
We determined whether XLF associates with active replication
forks in HEK293T cells by accelerated native iPOND (aniPOND;
Fig. 2 A; Sirbu et al., 2011, 2012; Leung et al., 2013; Wiest and
Tomkinson, 2017). Similar to PCNA, RFC1, and RAD51, which
associate with replication forks, XLF coprecipitates with nascent
DNA labeled with the thymidine analogue EdU (Fig. 2 A; Sirbu
et al., 2011). Moreover, XLF association decreases after thymi-
dine chase, demonstrating that XLF specifically associates with
active replication forks (Fig. 2 A). XRCC4 also associates with
DNA at active replication forks (Fig. 2 A). Treatment of
HEK293T cells with hydroxyurea (HU), which causes replication
fork stalling, leads to decreased association of PCNA and in-
creased association of RAD51 at replication forks (Fig. 2 A;
Ragland et al., 2013; Dungrawala et al., 2015; Zellweger et al.,
2015). HU treatment leads to a mild increase in XLF association
with nascent DNA (Fig. 2 A). We conclude that XLF associates
with replication forks.
XLF deficiency impairs replication fork dynamics
We analyzed DNA fibers in WT and Xlf−/− MEFs that were
consecutively incubated with 5-iodo-29-deoxyuridine (IdU; red)
and 5-chloro-29-deoxyuridine (CldU; green) to label newly
synthesized DNA tracts (Fig. 2 B). As compared with WT MEFs,
the lengths of the bicolor DNA tracts were significantly reduced
in Xlf−/− MEFs, and this reduction was corrected by the ectopic
expression of XLF (Fig. 2 B). There was a higher frequency of
DNA tracts labeled only with IdU (red) in Xlf−/− MEFs as com-
pared with WT MEFs (Fig. 2 C). The lengths of bidirectional
newly synthesized DNA tracts emerging from single replication
origins (two CldU tracts extending from a single IdU tract) were
measured (Fig. 2 D). Under conditions of unperturbed DNA
synthesis, the lengths of these newly synthesized DNA tracts
should be approximately equal. Indeed, inWTMEFs, the ratio of
the lengths of the bidirectional newly synthesized DNA tracts
are close to one (1.2; Fig. 2 D). In contrast, this value is signifi-
cantly greater (1.8) in Xlf−/− MEFs, indicating that loss of XLF
leads to increased replication fork asymmetry (Fig. 2 D). Xrcc4−/−
MEFs exhibit defects in DNA replication that are similar to those
observed in Xlf−/− MEFs (Fig. 2 E). Analyses of DNA ligase IV–
deficient (Lig4−/−) MEFs, which, like Xrcc4−/− MEFs, have a block
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in NHEJ, revealed no significant differences in newly synthe-
sized DNA tracts as compared with WT MEFs (Fig. 2 E). To-
gether, these data are indicative of a DNA replication defect due
to diminished replication fork progression, replication fork
stalling, or nucleolytic resection of newly synthesized DNA in
XRCC4- and XLF-deficient MEFs. Moreover, that DNA fiber
defects were not observed in Lig4−/− MEFs suggests that the
replication defects in Xlf−/− and Xrcc4−/− MEFs are not due to the
function of XLF and XRCC4 in promoting NHEJ.
Replication fork stalling can lead to fork regression, which is
best visualized by EM (Sogo et al., 2002; Vindigni and Lopes,
2017). We visualized the fine architecture of the replication in-
termediates using a combination of in vivo psoralen cross-
linking and EM (Fig. 2 F and Fig. S1; Neelsen et al., 2014).
Treating WTMEFs with HU leads to a significant increase in the
frequency of reversed forks (Fig. S1). Analysis of untreated Xlf−/−
MEFs reveals an increase in the frequency of reversed forks of
similar magnitude to that observed inWTMEFs treated with HU
(Fig. 2 F and Fig. S1). Lig4−/− MEFs do not exhibit an increase in
replication fork reversal, demonstrating that the reversed forks
in Xlf−/− MEFs are not due to a defect in NHEJ per se (Fig. S1).
Knockdown of RAD51, which is required for fork reversal, leads
to partial recovery of newly synthesized DNA tracts in Xlf−/−
MEFs (Fig. 2 G; Zellweger et al., 2015). Thus, XLF deficiency
leads to increased fork reversal during DNA replication.
ATR inhibition leads to increased DDR in XLF-deficient cells
XLF-deficient MEFs appear to divide normally, suggesting that
any replication defects are resolvable, likely through the acti-
vation of ATR. Indeed, as compared withWTMEFs, treatment of
Xlf−/− MEFs with the ATR kinase inhibitor VE-821 leads to DDR
activation, as indicated by increased γH2AX and phospho-KAP1
(pKAP1; Fig. 3 A and Fig. S2 A). This increased DDR is reduced
when Rad51 is knocked down, consistent with the notion that it
is due to replication fork reversal (Fig. 3 B). Treatment with the
ATM kinase inhibitor KU55933, but not the DNA-PKcs kinase
inhibitor NU7441, leads to abrogation of the DDR (Fig. 3 C). MEFs
deficient in XRCC4 also exhibit an enhanced DDR in response to
ATR inhibition (Fig. 3 D and Fig. S2 B). Moreover, both Xlf−/− and
Xrcc4−/− MEFs exhibit diminished survival in response to ATR
inhibition as compared with WT MEFs (Fig. 3 E and Fig. S2 C).
Thus, XLF- and XRCC4-deficient MEFs have DNA replication
Figure 1. CDC7-dependent XLF phosphoryla-
tion and associationwith replication proteins.
(A) Anti-XLF Western blot analysis of FLAG-HA-
XLF immunoprecipitated with anti-HA antibody
from MEFs untreated or treated with calf intes-
tine phosphatase (CIP) or with phosphatase in-
hibitor (Ph-i). (B and C) Whole cell lysates from
WT abl preB cells untreated or treated with
CDC7 inhibitor (CDC7i) for 24 h (B) or 8 h (C),
ATR inhibitor (ATRi), ATM inhibitor (ATMi), DNA-
PKcs inhibitor (DNA-PKcsi), or roscovitine for 8 h
were analyzed by Western blotting using the
anti-XLF antibody. (D and E) FLAG-HA–tagged
WT or mutant XLF expressed in Xlf−/− MEFs
and analyzed Western blotting of whole cell ly-
sates using anti-HA antibody. (F) Summary of
mass spectrometry analysis of XLF interacting
proteins isolated by immunoprecipitation of
FLAG-HA-XLF from abl preB cell lysate.
(G) FLAG-HA-XLF was immunoprecipitated (IP)
from Xlf−/− MEF cells using anti-HA and associ-
ated proteins identified by Western blotting with
the indicated antibodies. KAP1 or KU70 levels
were assayed as protein loading controls. All
Western blots shown here and in the rest of the
figures were repeated in two independently
generated cell lines, and representative images
are shown.
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Figure 2. XLF regulates replication fork dynamics. (A) 293T cells not labeled (1), labeled with EdU followed by thymidine chase (2), labeled with EdU (3), or
labeled with Edu followed by HU treatment (4) were subject to aniPOND, and the isolated proteins were analyzed by Western blotting. Shown is solubilized
chromatin (Input) and proteins eluted from streptavidin beads (Capture). (B)WT and Xlf−/−MEFs transduced with a control lentivirus (TRE-Empty) or lentivirus
with tetracycline-inducible XLF (TRE-Xlf) were consecutively labeled with IdU and CldU for 30 min each. Size distribution of total tract length (IdU+CldU)
scored from bicolor DNA fibers is shown with red lines representing median. At least 450 tracts were scored for each dataset from three independent ex-
periments (Mann–Whitney U; ****, P < 0.0001). (C) Frequency of IdU (red) only tracts in DNA fiber assay described in B (unpaired t test; *, P < 0.05).
(D) Representative image of a symmetric (WT) and an asymmetric (Xlf−/−) fork, and quantification of the ratio of the lengths of sister forks. The top and bottom
bars on the whiskers of the box-and-whisker plots represent the 90th and 10th percentiles. At least 40 bidirectional forks were analyzed in three independent
experiments. (E) Size distribution of total tract length from indicated MEFs as described in B. At least 450 tracts were scored for each dataset from three
independent experiments (Mann–Whitney U; ****, P < 0.0001). (F) Left: Electron micrograph of a representative reversed fork on enriched genomic DNA from
Xlf−/− cells. Inset: Magnified four-way junction at the reversed replication fork. The Daughter (D) and Parental (P) strands are indicated as is the Reversed arm
(R). The frequency of fork reversal in WT and Xlf−/− MEFs is shown for two independent experiments. The percentage of reversed forks and total number of
replication intermediates analyzed are indicated in parentheses. (G) Size distribution of tract lengths of bicolor DNA fibers from Xlf−/− cells expressing control
(shCT) and RAD51 (shRAD51) shRNAs labeled as described in B. At least 450 tracts were scored for each dataset from two independent experiments
(Mann–Whitney U; ns, non-significant; ****, P < 0.0001).
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defects that must be resolved by ATR to prevent the activation of
an ATM-dependent DDR.
H2AX deficiency amplifies the replication defect in Xlf−/− MEFs
ATR inhibition of either H2ax−/− or Xlf−/− MEFs leads to activation
of the DDR as indicated by pKAP1 (Fig. 4, A and B; and Fig. S2, D
and E). However, ATR inhibition of H2ax−/−:Xlf−/− MEFs leads to a
synergistic increase in pKAP1, suggesting that the combined loss of
H2AX and XLF leads to significant defects in DNA replication that
require ATR for resolution (Fig. 4, A and B; and Fig. S2, D and E).
Indeed, inhibition of DNA replication initiation by CDC7 limits
the DDR in H2ax−/−:Xlf−/− MEFs treated with the ATR inhibitor
(Fig. 4 C). Moreover, H2ax−/−:Xlf−/− MEFs exhibit a significant loss
of viability uponATR inhibition as comparedwithWT,H2ax−/−, or
Xlf−/− MEFs (Fig. 4 D and Fig. S2 F). This increased sensitivity and
DDR to ATR inhibition exhibited byH2ax−/−:Xlf−/−MEFs is not due
to XLF and H2AX function in NHEJ, as Lig4−/−MEFs do not exhibit
increased pKAP1 upon ATR inhibition (Fig. 4 E). Moreover, while
Lig4−/− and H2ax−/−:Xlf−/− MEFs both exhibit increased sensitivity
to ionizing radiatio indicative of NHEJ defects, only H2ax−/−:Xlf−/−
MEFs exhibit sensitivity to ATR inhibition (Fig. 4 F). Finally, a
neutral comet assay of H2ax−/−:Xlf−/− MEFs treated with the ATR
inhibitor did not reveal a detectable increase in unrepaired two-
ended DSBs (Fig. 4 G). Together, these data demonstrate that XLF
and H2AX have NHEJ-independent functions during DNA repli-
cation, preventing the formation of lesions that, if not resolved by
ATR, lead to a robust DDR and cell death.
Replication defects in H2ax−/−:Xlf−/− MEFs
The regressed arm of a reversed fork generates a one-ended
DNA DSB that could activate a DDR. In G1-phase cells, γH2AX
protects DNA ends from resection; therefore, it is possible that
γH2AX protects regressed arms from being resected, which
would activate a DDR and prevent fork restart. In agreement,
complementation ofH2ax−/−:Xlf−/−MEFswithWTH2AX, but not
a serine 139 to alanine mutant of H2AX (H2AXS139A), which
cannot form γH2AX, leads to reduced pKAP1 formation in re-
sponse to ATR inhibition (Fig. 5 A). To determine whether
γH2AX may function by protecting the regressed arm from re-
section, we initially examined newly synthesized DNA tracts in
MEFs treated with the ATR inhibitor (Fig. 5 B). There was no
significant difference in these tracts when comparing WT and
H2ax−/− MEFs treated with the ATR inhibitor (Fig. 5 B). In
contrast, after ATR inhibition, Xlf−/− MEFs exhibited shorter
tract lengths, and H2ax−/−:Xlf−/− MEFs markedly shorter tract
lengths, when compared with WT MEFs (Fig. 5 B). Moreover,
after ATR inhibition, H2ax−/−:Xlf−/− MEFs had significantly
fewer reversed forks as compared with Xlf−/− MEFs by EM
analysis (Fig. 5 C). Together, these findings are consistent with
the notion that in the absence of H2AX, regressed arms of re-
versed replication forks may be resected. Notably, H2ax−/−:Xlf−/−
MEFs have slightly longer newly synthesized DNA tract lengths
than Xlf−/− MEFs, suggesting that H2AX could have additional
roles in promoting replication fork reversal under unperturbed
conditions (Fig. 5 B).
Figure 3. ATR inhibition leads to DDR in Xlf−/− cells. (A) Cell lysates from Xlf−/− MEFs treated with ATRi for the indicated times were analyzed by Western
blotting using the indicated antibodies. (B) Cell lysates from Xlf−/−MEFs transduced with Control (shCT) or RAD51 (shRAD51) shRNAs and treated with ATRi for
8 h were analyzed by Western blotting using the indicated antibodies. (C) Cell lysates from Xlf−/− MEFs untreated or pretreated with ATMi or DNA-PKcsi for
30 min before treatment with ATRi for 8 h were analyzed by Western blotting using the indicated antibodies. (D) Western blot analysis of whole cell lysates
from WT and Xrcc4−/− MEFs treated with ATRi for indicated times using the indicated antibodies. (E) Cell viability of WT, Xlf−/−, or Xrcc4−/− MEFs treated with
the ATRi at indicated concentrations for 4 d. Error bars indicating SD of three technical repeats from a representative experiment from analyses of two
independent cell lines of each genotype analyzed in two experiments, each in triplicate.
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DNA end resection is initiated by MRE11 and CtIP (Lengsfeld
et al., 2007; Sartori et al., 2007).MRE11 mediates the degradation
of reversed replication forks in BRCA1- and BRCA2-deficient
cells (Schlacher et al., 2011; Ray Chaudhuri et al., 2016;
Kolinjivadi et al., 2017; Lemaçon et al., 2017; Mijic et al., 2017;
Taglialatela et al., 2017). If γH2AX protects regressed arms from
resection, then the replication defects observed in H2ax−/−:Xlf−/−
MEFs should be dependent on MRE11 nuclease activity. Indeed,
inhibition of MRE11 nuclease activity with mirin leads to a re-
duction in the DDR in H2ax−/−:Xlf−/− MEFs treated with the ATR
inhibitor (Fig. 5 D and Fig. S2 G). Moreover, DNA tracts were
significantly longer in ATR inhibitor–treated H2ax−/−:Xlf−/−
MEFs that were also treated with mirin (Fig. 5 E). Mirin treat-
ment of ATR-treated Xlf−/− MEFs led to an increase in DNA tract
length, suggesting that even in the presence of H2AX, regressed
arms may undergo some resection (Fig. 5 E). Indeed, pKAP1 and
γH2AX levels in Xlf−/− MEFs in response to ATR inhibition are
also abrogated by mirin treatment (Fig. 5 F and Fig. S2 H). In
agreement, another study found that the DNA tract length
shortening in human cells expressing H2AX S139A also depends
on Mre11 activity (Schmid et al., 2018). Notably, deficiency of
53BP1, which is recruited to DNA DSBs by γH2AX and antago-
nizes DNA end resection in mammalian cells, or deficiency in
the yeast 53BP1 counterpart, Rad9, also leads to degradation of
DNA at stalled replication forks (Bunting et al., 2010; Her et al.,
2018; Schmid et al., 2018; Villa et al., 2018). We conclude that the
defects in newly synthesized DNA tracts, and the resulting DDR,
observed in H2ax−/−:Xlf−/− MEFs are dependent on MRE11 nu-
clease activity.
We have shown that XLF functions during DNA replication in
a manner that is independent of NHEJ. Moreover, loss of XRCC4
leads to DNA replication defects that are similar to those ob-
served in Xlf−/− cells, suggesting that XLF-XRCC4 filament for-
mation, which functions during NHEJ, may also function during
DNA replication to prevent or resolve reversed DNA replication
forks. H2AX deficiency synergistically exacerbates the replica-
tion defects and DDR activation in Xlf−/− MEFs, suggesting
that the defects imposed by the loss of these proteins are
Figure 4. H2AX deficiency enhances replica-
tion defects in Xlf−/− MEFs. (A) Whole cell ly-
sates from MEFs of the indicated genotypes
untreated or treated with ATRi for the indicated
time were analyzed by Western blotting for
pKAP1. (B) Quantification of pKAP1 levels nor-
malized to KAP1 shown in A. (C) Western blot
analysis of pKAP1 in H2ax−/−:Xlf−/− MEFs un-
treated or treated with ATRi, CDC7 inhibitor
(CDC7i), or both. (D and F)MEFs of the indicated
genotype were treated with ATRi and viability
assayed as described in Fig. 3 E. IR, ionizing ra-
diation. Error bars indicate SD from three repli-
cates. (E) Western blot analysis of pKAP1 in
whole cell lysates from MEFs of the indicated
genotype untreated or treated with ATRi for 8 h.
(G) Tail moments in a neutral comet assay of
MEFs of the indicated genotype untreated or
treated with ATRi for 8 h. Red lines indicate
median. WT MEFs treated with 20 µg/ml of
bleocin (bleo) for 2 h is shown as a positive
control.
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mechanistically in series. Moreover, this exacerbation of rep-
lication defects in H2ax−/−:Xlf−/− MEFs depends on MRE11 ac-
tivity. We propose that XLF functions during DNA replication
to prevent the accumulation of reversed replication forks and
that when a reversed fork is generated γH2AX functions to
prevent MRE11-dependent resection of the regressed arm and
DDR activation (Fig. 5 G). Thus, the lymphopenia observed in
XLF-deficient humans and embryonic lethality observed in
Figure 5. MRE11-mediated replication defects in H2ax−/−:Xlf−/− MEFs. (A) Cell lysates from H2ax−/−:Xlf−/− MEFs expressing WT or S139A mutant H2AX,
treated with ATRi for 8 h, were analyzed by Western blotting using the indicated antibodies. (B) DNA tract lengths in ATRi treated or untreated MEFs of the
indicated genotype were assayed as described in Fig. 2 B. At least 450 tracts were scored for each dataset from three independent experiments (Mann–
Whitney U; ***, P < 0.001; ****, P < 0.0001). (C) Frequency of reversed forks in Xlf−/− and H2ax−/−:Xlf−/− MEFs treated with ATRi for 3 h before EM analysis as
described in Fig. 2 F. (D) pKAP1 analysis in whole cell lysates from H2ax−/−:Xlf−/− MEFs treated with ATRi, mirin, or both were analyzed by Western blotting.
(E) DNA tract lengths in ATRi treated MEFs of the indicated genotype in the presence or absence of mirin were assayed as described in Fig. 2 B. At least 450
tracts were scored for each dataset from three independent experiments (Mann–Whitney U; ns, non-significant; ****, P < 0.0001). (F)Whole cell lysates from
Xlf−/−MEFs treated with ATRi, mirin, or both were analyzed by Western blotting for the indicated proteins. (G) A model for replication defects caused by H2AX
and XLF deficiency as described in the text.
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H2ax−/−:Xlf−/− mice may be due, in part, to the requirement for
XLF and H2AX during DNA replication. Although this seems at
odds with the growth of H2ax−/−:Xlf−/− and Xlf−/− MEFs in cell
culture, this growth is more dependent on ATR activity than
WT MEFs. Moreover, different cell types could have differen-
tial requirements for pathways that promote efficient DNA
replication. Indeed, embryonic stem cells exhibit decreased
replication fork speed, increased fork reversal, and a higher
level of associated DDR activation (Ahuja et al., 2016).
Materials and methods
Cells culture and chemicals
Abl preB cells were generated as described previously
(Bredemeyer et al., 2006). MEFs were generated from embry-
onic day 13.5 embryos of mice that are Xlf+/+ or Xlf−/− carrying
conditional H2ax alleles (H2axcon/con) flanked by loxP sites.
Multiple H2axcon/con:Xlf+/+ and H2axcon/con:Xlf−/− primary MEFs
were generated from two mice. Primary MEFs were propagated
for two passages before being immortalized with SV40 large T
antigen. Cre recombinase was transiently introduced to these
cells to generate H2ax−/-:Xlf+/+ or H2ax−/−:Xlf−/− cells. MEFs used
in this work were derived from embryos from each mouse: the
first set (from mouse 1) includes H2axcon/con:Xlf+/+ (WT, AB-2),
H2ax−/− (AB-4), H2axcon/con:Xlf−/− (Xlf−/−, AB-2), and H2ax−/−:
Xlf−/− (AB-8); the second set (frommouse 2) includes H2axcon/con:
Xlf+/+ (WT, 4A-8),H2ax−/− (4A-9),H2axcon/con:Xlf−/− (Xlf−/−, 2A-8),
and H2ax−/−:Xlf−/− (2A-1). Ectopic expression of XLF in Xlf−/−
MEFs was achieved by transducing cells with lentivirus ex-
pressing XLF inducibly under a tetracycline-regulated element
(TRE) promoter and treating cells with 0.1 µg/ml of doxycycline
for 7 d. All cells were cultured in DMEM supplemented with 10%
fetal bovine serum and 0.4% β-mercaptoethanol. ATR inhibitor
VE-821(10 µM; S8007), ATM inhibitor KU55933 (15 µM; S1092),
DNA-PKcs inhibitor NU7441 (10 µM; S2638), CDC7 inhibitor
PHA-767491 (5 µM or 10 µM; S2742), and CDK inhibitor rosco-
vitine (10 µM; S1153) were purchased from Selleckchem. MRE11
inhibitor mirin was purchased from Sigma-Aldrich (50 µM;
M9948).
Immunoprecipitation and Western blotting
For nuclear extract immunoprecipitation, cells were lysed in
cytoplasmic extraction buffer (10 mM Tris-HCl, pH 7.4, 10 mM
KCl, 1.5 mM MgCl2, 1 mM EDTA, and 0.05% Triton X-100) sup-
plemented with a protease and phosphatase inhibitor cocktail on
ice for 15 min. After centrifugation at 3,000 rpm, 4°C for 5 min,
the pellet was washed with cytoplasmic extraction buffer and
incubated in 0.5× pellet volume of nuclease buffer (20 mM Tris-
HCl, pH 7.4, 1.5 mMMgCl2, and 25% vol/vol glycerol) with 5 U/µl
benzonase (E1014; Sigma-Aldrich) on ice for 1 h to digest genomic
DNA. 1× pellet volume of nuclear extraction buffer (20 mM Tris-
HCl, pH 7.4, 500mMKCl, 1.5 mMMgCl2, 0.2 mMEDTA, and 25%
vol/vol glycerol) was then added, and the pellet was ground
using a dounce tissue grinder (D8938; Sigma-Aldrich) before
incubation with gentle rotation at 4°C for 1 h. The lysate was
clarified by centrifugation at 15,000 rpm, 4°C for 30min, and the
supernatant was dialyzed in BC100 buffer (20 mM Tris-HCl, pH
7.4, 100 mMKCl, 0.2 mMEDTA, and 20% vol/vol glycerol) at 4°C
overnight using the Pur-A-Lyzer Maxi 6000 Kit (PURX60015;
Sigma-Aldrich). The dialyzed supernatant was clarified again by
centrifugation at 15,000 rpm, 4°C for 30min, and incubated with
EZView Red HA affinity gel beads (E6779; Sigma-Aldrich) on a
rotator at 4°C for 4 h. The beads were washed four times with
TAP buffer (50 mM Tris-HCl, pH 7.4, 100 mM KCl, 5 mMMgCl2,
0.2 mM EDTA, 10% vol/vol glycerol, and 0.1% vol/vol Triton X-
100). Protein complexes were eluted by boiling in LDS sample
buffer (NP0007; Thermo Fisher Scientific) and resolved in 4–12%
NuPAGE Bis-Tris gels for Western blotting. For detecting phos-
phorylated XLF, protein was resolved in 10% Tris-Glycine gels
for Western blotting analysis. Anti-XLF, anti-PCNA, and anti-
pKAP1 (S824) antibodies (all produced in rabbits) were ob-
tained from Bethyl Laboratories (A7300-730A, A300-276A, and
A300-767A, respectively). Anti-KAP1 and anti-RFC4 anti-
bodies were obtained from Genetex (GTX10484, rabbit, and
GTX104052, rabbit, respectively). Anti-KU70 (D10A7) antibody
was obtained from Cell Signaling Technologies (4588S, rabbit).
Anti-phospho-histone H2AX (S139), γH2AX, clone JBW301,
anti-H2AX, and anti-RAD51 antibodies were obtained from
EMD Millipore (05–636, mouse; 07–627, rabbit; and 07–1782,
rabbit, respectively). Anti-histone H3 and anti-RFC1 antibodies
were obtained from Abcam (ab1791, rabbit, and ab193559,
rabbit, respectively). Anti-XRCC4 (C-20) was obtained from
Santa Cruz Biotechnology (sc-8285, goat).
Mass spectrometry
Immunoprecipitation for mass spectrometry was described
previously (Ciccia et al., 2009). Briefly, lentiviral construct TRE-
FLAG-HA-XLF was used to transduce Xlf−/− abl-preB cells. 150
million transduced cells were treated with 3 µM imatinib and
0.2 µg/ml doxycycline for 48 h before harvesting for protein
lysates in low-salt buffer (50mMTris, pH 7.5, 150mMNaCl, and
1% NP-40) supplemented with protease inhibitor (P8340;
Sigma-Aldrich) and phosphatase inhibitor cocktails 2 and 3
(P0044 and P5726; Sigma-Aldrich). Cell lysis was performed on a
rotator at 4°C for 30 min and then centrifuged at 14,000 rpm for
20 min. Cell pellets were resuspended in high-salt buffer
(50 mM Tris, pH 7.5, 500 mM NaCl, and 1% NP-40) and incu-
bated on a rotator at 4°C for 1 h, followed by centrifugation at
14,000 rpm for 20 min. The high- and low-salt extracts were
mixed together, and the salt concentration was adjusted to
150 mM NaCl. The final cell lysate was precleared with protein
A/G agarose (sc-2003; Santa Cruz Biotechnology), and pre-
cleared lysate was immunoprecipitated with anti-HA agarose
(sc-7392 AC; Santa Cruz Biotechnology) overnight at 4°C. Pre-
cipitated protein complex was washed five times in low-salt
buffer and eluted with HA peptide (500 µg/ml; I2149; Sigma-
Aldrich). Eluted proteins were TCA-precipitated and analyzed
by tandem mass spectrometry at the Taplin Mass Spectrometry
Facility at Harvard Medical School.
AniPOND analysis
AniPOND analysis was performed as previously described with
some modifications (Leung et al., 2013; Wiest and Tomkinson,
2017). Cells were pulse-labeled with 10 µM EdU in DMEM for
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15 min, washed with PBS, and then incubated in medium with
10 µM thymidine for 1 h or with 4 mMHU for 2 h. After labeling,
cells were immediately lysed and harvested with nuclei ex-
traction buffer (20 mM Hepes, pH 7.2, 40 mM NaCl, 3 mM
MgCl2, 300 mM sucrose, and 0.5% NP-40). Nuclei pellets were
washed with 1× PBS, resuspended in click reaction mix (in order
of addition: 25 mM biotin picolyl azide [Click Chemistry Tools],
10 mM (+)-sodium l-ascorbate, and 2 mM CuSO4) and rotated at
4°C for 1 h. Samples were then washed with 1× PBS. The re-
sulting pellets were resuspended in 500 µl Buffer B1 (25 mM
NaCl, 2 mM EDTA, 50 mM Tris-HCl, pH 8.0, 1% NP-40, and
protease inhibitors), rotated for 30min at 4°C, and spun down at
maximum speed for 10 min at 4°C. The above procedure was
repeated once more, and the resulting nuclei were resuspended
in 500 µl Buffer B1. Samples were then sonicated using a Model
50 Sonic Dismembrator (Thermo Fisher Scientific) 12 × 10 s at 20
amplitude to solubilize DNA-bound proteins. Samples were spun
down at maximum speed for 10 min, and the supernatant was
collected. 500 µl Buffer B2 (150 mM NaCl, 2 mM EDTA, 50 mM
Tris-HCl, pH 8.0, 0.5% NP-40, and protease inhibitors) was
added to the supernatant to bring the total sample size to ∼1 ml.
Samples were rotated overnight (16–20 h) with streptavidin
beads (Thermo Fisher Scientific). A chromatin input sample was
collected immediately before streptavidin capture. Beads were
washed extensively with Buffer B2, and captured proteins were
eluted by boiling in Laemmli buffer.
EM of replication intermediates
EM analysis of replication intermediates was performed as
previously described (Neelsen et al., 2014). Briefly, 5–10×106
asynchronously growing MEFs were collected, and genomic
DNAwas cross-linked by three rounds of incubation in 10 µg/ml
4,59,8-trimethylpsoralen (T6137; Sigma-Aldrich) and 3 min of
irradiation with 366 nm UV light on a precooled metal block.
Cells were lysed, and genomic DNA was isolated from the nuclei
by proteinase K digestion and phenol-chloroform extraction.
DNA was purified by isopropanol precipitation, digested with
PvuII High Fidelity for 3–5 h at 37°C, and replication inter-
mediates were enriched on a benzoylated naphthoylated
DEAE–cellulose (B6385; Sigma-Aldrich) column. EM samples
were prepared by spreading the DNA on carbon-coated grids in
the presence of benzyl dimethylalkylammonium chloride and
visualized by platinum rotary shadowing. Images were acquired
on a transmission electron microscope (JEOL 1200 EX) with
side-mounted camera (AMTXR41 supported by AMT software
v601) and analyzed with ImageJ (National Institutes of Health).
DNA fiber assay
The DNA fiber assay was performed as described previously
(Quinet et al., 2017a). Briefly, MEFs were labeled with two
thymidine analogues: 20 µM IdU (I7125; Sigma-Aldrich) fol-
lowed by 200 µM CldU (C6891; Sigma-Aldrich) for the indicated
times. Where indicated, ATR inhibitor (10 µM) and mirin
(50 µM) were added 2 h before labeling and remained in culture
during the course of the experiments. Labeled cells were re-
suspended in 1× PBS at 106 cells/ml. 2 µl of cell suspension was
mixed with 6 µl of lysis buffer (200 mM Tris–HCl, pH 7.5,
50 mM EDTA, and 0.5% SDS) on a glass slide. After 5 min, the
slides were tilted at a 15–45° angle, and the resulting DNA
spreads were air-dried, fixed in 3:1 methanol/acetic acid for
5 min, and stored at 4°C. The DNA fibers were denatured with
2.5 M HCl for 1 h, washed with 1× PBS, and blocked with 5% BSA
in 1× PBS for 1 h. DNA immunostaining was performed with rat
anti-BrdU antibody (1:100; Ab6326; Abcam) for CldU and mouse
anti-BrdU antibody (1:20; 347580; Becton Dickson) for IdU in a
humid chamber at room temperature for 1 h. The following
secondary antibodies were used: anti-rat Alexa Fluor 488 (1:100;
A21470; Molecular Probes) and anti-mouse Alexa Fluor 546
(1:100; A21123; Molecular Probes) at room temperature for 1 h.
The slides were air-dried and mounted with Prolong Gold Anti-
Fade reagent (P36930; Invitrogen). Images were acquired with
LAS AF software using a TCS SP5 confocal microscope (Leica).
The DNA tract lengths were measured using ImageJ. Only bi-
color fibers were scored, and the total length (IdU + CldU) per
fiber is presented in micrometers. Statistical analysis (Mann-
Whitney U) was performed using GraphPad Prism Software.
Cell survival assay
PrestoBlue Cell Viability Reagent (A13261; Thermo Fisher Sci-
entific) was used to estimate the fraction of viable cells present
in 24-well plates after treating 3,000 cells/well with ATR in-
hibitor VE-821 for 4 d. The drug-containing media were then
replaced with 0.5 ml of 1× PrestoBlue in growth media followed
by incubation for 3 h at 37°C. The absorbance was recorded at
560 nm (experimental wavelength) and 570 nm (reference
wavelength) using a Multiskan Ascent plate reader (Thermo
Fisher Scientific).
Online supplemental material
All the peptides identified in our mass spectrometry analysis of
XLF interaction proteins are available in Table S1. Additional
analyses of reversed replication forks by EM and images are
shown in Fig. S1. Independent biological replicates of Western
blots are shown in Fig. S2.
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Figure S1. XLF deficiency promotes replication fork reversal. Related to Fig. 2. (A) Frequency of fork reversal in WT, Xlf−/−, and Lig4−/− MEFs. Cells were
treated with 2 mM HU (1 h) where indicated. The percentage values of reversed forks and total number of replication intermediates analyzed (in parentheses)
are indicated on the top of the bar. (B and C) Electron micrographs of a replication fork (B) and reversed replication forks (C) observed on enriched genomic
DNA in Xlf−/−MEFs or WTMEFs treated with HU. Right: Magnified three-way junction (B) or four-way junction at the reversed replication fork (C). D, Daughter
strand; P, Parental strand; R, Reversed arm. For the criteria used for the assignment of reversed forks, see Vindigni and Lopes (2017) and Neelsen et al. (2014).
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Figure S2. Biological replicates of keyWestern blots and survival assays in independently generated set of MEFs. Related to Figs. 3, 4, and 5. (A and B)
The indicated MEFs were treated with 10 µM ATRi for indicated times. Whole cell lysate was collected and analyzed with antibodies specified byWestern blot.
(C) WT, Xlf−/−, and Xrcc4−/− MEFs were treated with ATRi at indicated concentrations for 4 d. Cell survival was determined with PrestoBlue Cell Viability
Reagent. Error bars indicate SD of three technical repeats in the experiment. (D)Whole cell lysate fromWT, H2ax−/−, Xlf−/−, or H2ax−/−:Xlf−/−MEFs untreated or
treated with 10 µM of ATR inhibitor for 4, 8, or 22 h was analyzed by Western blot with indicated antibodies. (E) Quantification of D. (F)WT, H2ax−/−, Xlf−/−, or
H2ax−/−:Xlf−/− MEFs were treated with ATR inhibitor at indicated concentrations for 4 d and analyzed as in C. (G and H) H2ax−/−:Xlf−/− (G) or Xlf−/− (H) MEFs
were treated with 10 µM ATRi, 50 µMmirin, or both. Whole cell lysate was prepared and analyzed with indicated antibodies. Western blots in A, B, D, E, G, and
H and the survival assays in C and F are representative data on a second set of independently generated cells (data on the other set of cell lines are shown in
main figures).
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